By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Halberd Corporation (HALB)

OTC Currency in USD
$0.00
$0.00
+27.27%
Last Update: 29 Aug 2025, 19:51
$1.44M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.01
52 Week Range

HALB Stock Price Chart

Explore Halberd Corporation interactive price chart. Choose custom timeframes to analyze HALB price movements and trends.

HALB Company Profile

Discover essential business fundamentals and corporate details for Halberd Corporation (HALB) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

25 Sept 2012

Employees

CEO

William A. Hartman

Description

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

HALB Financial Timeline

Browse a chronological timeline of Halberd Corporation corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

HALB Stock Performance

Access detailed HALB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run